| Percutaneous penetration enhancers physical methods in penetration enhancement N Dragicevic, HI Maibach Springer Berlin Heidelberg, 2017 | 257 | 2017 |
| Development of an ointment formulation using hot-melt extrusion technology AM Bhagurkar, M Angamuthu, H Patil, RV Tiwari, A Maurya, ... Aaps Pharmscitech 17, 158-166, 2016 | 73 | 2016 |
| Iontophoretic drug delivery for the treatment of scars P Manda, M Angamuthu, SR Hiremath, V Raman, SN Murthy Journal of pharmaceutical sciences 103 (6), 1638-1642, 2014 | 30 | 2014 |
| Controlled-release injectable containing Terbinafine/PLGA microspheres for Onychomycosis Treatment M Angamuthu, SH Nanjappa, V Raman, S Jo, P Cegu, SN Murthy Journal of Pharmaceutical Sciences 103 (4), 1178-1183, 2014 | 21 | 2014 |
| Water activity and its significance in topical dosage forms M Angamuthu, VK Shankar, SN Murthy Journal of Pharmaceutical Sciences 107 (6), 1656-1666, 2018 | 12 | 2018 |
| Rapid screening approaches for solubility enhancement, precipitation inhibition and dissociation of a cocrystal drug substance using high throughput experimentation MN Bahr, M Angamuthu, S Leonhardt, G Campbell, SH Neau Journal of Drug Delivery Science and Technology 61, 102196, 2021 | 11 | 2021 |
| Role of physical, chemical percutaneous penetration enhancement methods: a concise review M Angamuthu, S Ainampudi J Nanomed Biother Discov 7, 2017 | 5 | 2017 |
| Therapeutic applications of electroporation M Angamuthu, SN Murthy Percutaneous Penetration Enhancers Physical Methods in Penetration …, 2017 | 4 | 2017 |
| Quality by Design (QbD) principles in the development of transdermal drug delivery products M Angamuthu, HN Shivakumar, SN Murthy Dermal Drug Delivery, 163-184, 2020 | 2 | 2020 |
| Critical Quality Attributes of Topical Semi-solid Dosage Forms: Solvent Activity M Angamuthu | 1 | 2016 |
| and S. Narasimha Murthy M Angamuthu Percutaneous Penetration Enhancers Physical Methods in Penetration …, 2017 | | 2017 |
| tabletting M Angamuthu, S Ainampudi, J Sturgis Jr | | |
